Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma

GD2-targeting immunotherapies have improved survival in children with neuroblastoma, yet on-target, off-tumor toxicities can occur and a subset of patients cease to respond. The majority of neuroblastoma patients who receive immunotherapy have been previously treated with cytotoxic chemotherapy, mak...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jasmine Y., Jonus, Hunter C., Sadanand, Arhanti, Branella, Gianna M., Maximov, Victor, Suttapitugsakul, Suttipong, Schniederjan, Matthew J., Shim, Jenny, Ho, Andrew, Parwani, Kiran K., Fedanov, Andrew, Pilgrim, Adeiye A., Silva, Jordan A., Schnepp, Robert W., Doering, Christopher B., Wu, Ronghu, Spencer, H. Trent, Goldsmith, Kelly C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314120/
https://www.ncbi.nlm.nih.gov/pubmed/37343516
http://dx.doi.org/10.1016/j.xcrm.2023.101091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314120/
https://www.ncbi.nlm.nih.gov/pubmed/37343516
http://dx.doi.org/10.1016/j.xcrm.2023.101091

Ejemplares similares